Literature DB >> 16517718

Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells.

Alison Crawford1, Megan Macleod, Ton Schumacher, Louise Corlett, David Gray.   

Abstract

B cells are well documented as APC; however, their role in supporting and programming the T cell response in vivo is still unclear. Studies using B cell-deficient mice have given rise to contradictory results. We have used mixed BM chimeric mice to define the contribution that B cells make as APC. When the B cell compartment is deficient in MHC class II, while other APC are largely normal, T cell clonal expansion is significantly reduced and the differentiation of T cells into cytokine-secreting effector cells is impaired (in particular, Th2 cells). The development of the memory T cell populations is also decreased. Although MHC class II-mediated presentation by B cells was crucial for an optimal T cell response, neither a B cell-specific lack of CD40 (influencing costimulation) nor lymphotoxin alpha (influencing lymphoid tissue architecture) had any effect on the T cell response. We conclude that in vivo B cells provide extra and essential Ag presentation capacity over and above that provided by dendritic cells, optimizing expansion and allowing the generation of memory and effector T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517718     DOI: 10.4049/jimmunol.176.6.3498

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  132 in total

1.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  CD8 T-cell proliferative capacity is compromised in primary HIV-1 infection.

Authors:  Sonya L Heath; Steffanie Sabbaj; Anju Bansal; J Michael Kilby; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

Review 3.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

4.  Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching.

Authors:  Jason S Ellis; F Betul Guloglu; Habib Zaghouani
Journal:  Immunology       Date:  2016-01-28       Impact factor: 7.397

Review 5.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

6.  Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.

Authors:  Shahrooz S Kelishadi; Agnes M Azimzadeh; Tianshu Zhang; Tiffany Stoddard; Emily Welty; Christopher Avon; Mitch Higuchi; Amal Laaris; Xiang-Fei Cheng; Christine McMahon; Richard N Pierson
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

7.  Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells.

Authors:  M Gray; K Miles; D Salter; D Gray; J Savill
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

8.  Temporal requirements for B cells in the establishment of CD4 T cell memory.

Authors:  Sarah B Mollo; Allan J Zajac; Laurie E Harrington
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

Review 9.  Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.

Authors:  Noam Jacob; William Stohl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

10.  Peripheral CD4(+) T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsets.

Authors:  Susan E Murray; Katelynne Gardner Toren; David C Parker
Journal:  Eur J Immunol       Date:  2013-05-08       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.